Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články, metaanalýza, systematický přehled
PubMed
31683759
PubMed Central
PMC6893436
DOI
10.3390/nu11112611
PII: nu11112611
Knihovny.cz E-zdroje
- Klíčová slova
- complications, diet, lifestyles, prevention, type 2 diabetes,
- MeSH
- cvičení * MeSH
- diabetes mellitus 2. typu prevence a kontrola MeSH
- dieta * MeSH
- glukózový toleranční test MeSH
- komplikace diabetu prevence a kontrola MeSH
- lidé MeSH
- zdravé chování * MeSH
- životní styl * MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- systematický přehled MeSH
Prevention of type 2 diabetes (T2D) is a great challenge worldwide. The aim of this evidence synthesis was to summarize the available evidence in order to update the European Association for the Study of Diabetes (EASD) clinical practice guidelines for nutrition therapy. We conducted a systematic review and, where appropriate, meta-analyses of randomized controlled trials (RCTs) carried out in people with impaired glucose tolerance (IGT) (six studies) or dysmetabolism (one study) to answer the following questions: What is the evidence that T2D is preventable by lifestyle changes? What is the optimal diet (with a particular focus on diet quality) for prevention, and does the prevention of T2D result in a lower risk of late complications of T2D? The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was applied to assess the certainty of the trial evidence. Altogether seven RCTs (N = 4090) fulfilled the eligibility criteria and were included in the meta-analysis. The diagnosis of incident diabetes was based on an oral glucose tolerance test (OGTT). The overall risk reduction of T2D by the lifestyle interventions was 0.53 (95% CI 0.41; 0.67). Most of the trials aimed to reduce weight, increase physical activity, and apply a diet relatively low in saturated fat and high in fiber. The PREDIMED trial that did not meet eligibility criteria for inclusion in the meta-analysis was used in the final assessment of diet quality. We conclude that T2D is preventable by changing lifestyle and the risk reduction is sustained for many years after the active intervention (high certainty of evidence). Healthy dietary changes based on the current recommendations and the Mediterranean dietary pattern can be recommended for the long-term prevention of diabetes. There is limited or insufficient data to show that prevention of T2D by lifestyle changes results in a lower risk of cardiovascular and microvascular complications.
Department of Clinical Medicine and Surgery Federico 2 University 80138 Naples Italy
Department of Endocrinology and Internal Medicine Aarhus University Hospital 8200 Aarhus N Denmark
German Center for Diabetes Research 85764 München Neuherberg Germany
Institute for Clinical and Experimental Medicine 140 21 Prague Czech Republic
Li Ka Shing Knowledge Institute St Michael's Hospital Toronto M5B 1T8 ON Canada
Physicians Committee for Responsible Medicine Washington DC 20016 USA
Zobrazit více v PubMed
International Diabetes Federation . IDF Atlas. 8th ed. International Diabetes Federation; Brussels, Belgium: 2017.
World Health Organization . Global Report on Diabetes 2016. WHO; Geneva, Switzerland: 2017.
Davies M.J., D’Alessio D.A., Fradkin J., Kernan W.N., Mathieu C., Mingrone G., Rossing P., Tsapas A., Wexler D.J., Buse J.B. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia. 2018;61:2461–2498. doi: 10.1007/s00125-018-4729-5. PubMed DOI
Gloy V.L., Briel M., Bhatt D.L., Kashyap S.R., Schauer P.R., Mingrone G., Bucher H.C., Nordmann A.J. Bariatric surgery versus non-surgical treatment for obesity: A systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:5934. doi: 10.1136/bmj.f5934. PubMed DOI PMC
Douglas I.J., Bhaskaran K., Batterham R.L., Smeeth L. Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care. PLoS Med. 2015;12:e1001925. doi: 10.1371/journal.pmed.1001925. PubMed DOI PMC
World Health Organization . Diabetes Mellitus, Report of a WHO Study Group. WHO; Geneva, Switzerland: 1985. WHO Technical Report. PubMed
Mann J.I., De Leeuw I., Hermansen K., Karamanos B., Karlstrom B., Katsilambros N., Riccardi G., Rivellese A.A., Rizkalla S., Slama G., et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 2004;14:373–394. doi: 10.1016/S0939-4753(04)80028-0. PubMed DOI
Higgins J.P.T., Green S. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collaboration; Oxford, UK: 2011.
Schellenberg E.S., Dryden D.M., Vandermeer B., Ha C., Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: A systematic review and meta-analysis. Ann. Intern. Med. 2013;159:543–551. doi: 10.7326/0003-4819-159-8-201310150-00007. PubMed DOI
Barry E., Roberts S., Oke J., Vijayaraghavan S., Normansell R., Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: Systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356:6538. doi: 10.1136/bmj.i6538. PubMed DOI
Haw J.S., Galaviz K.I., Straus A.N., Kowalski A.J., Magee M.J., Weber M.B., Wei J., Narayan K.M.V., Ali M.K. Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern. Med. 2017;177:1808–1817. doi: 10.1001/jamainternmed.2017.6040. PubMed DOI PMC
Hemmingsen B., Gimenez-Perez G., Mauricio D., Roque I.F.M., Metzendorf M.I., Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2017;12:003054. doi: 10.1002/14651858.CD003054.pub4. PubMed DOI PMC
Brunetti M., Shemilt I., Pregno S., Vale L., Oxman A.D., Lord J., Sisk J., Ruiz F., Hill S., Guyatt G.H., et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J. Clin. Epidemiol. 2013;66:140–150. doi: 10.1016/j.jclinepi.2012.04.012. PubMed DOI
Balshem H., Helfand M., Schunemann H.J., Oxman A.D., Kunz R., Brozek J., Vist G.E., Falck-Ytter Y., Meerpohl J., Norris S., et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 2011;64:401–406. doi: 10.1016/j.jclinepi.2010.07.015. PubMed DOI
Higgins J.P.T., Green S. Cochrane Handbook for Systematic Reviews of Interventions. Wiley; Hoboken, NJ, USA: 2008. p. 672.
Thompson S.G., Higgins J.P. How should meta-regression analyses be undertaken and interpreted? Stat. Med. 2002;21:1559–1573. doi: 10.1002/sim.1187. PubMed DOI
Sterne J.A., Gavaghan D., Egger M. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J. Clin. Epidemiol. 2000;53:1119–1129. doi: 10.1016/S0895-4356(00)00242-0. PubMed DOI
Guyatt G., Oxman A.D., Akl E.A., Kunz R., Vist G., Brozek J., Norris S., Falck-Ytter Y., Glasziou P., DeBeer H., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol. 2011;64:383–394. doi: 10.1016/j.jclinepi.2010.04.026. PubMed DOI
Guyatt G., Oxman A.D., Sultan S., Brozek J., Glasziou P., Alonso-Coello P., Atkins D., Kunz R., Montori V., Jaeschke R., et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J. Clin. Epidemiol. 2013;66:151–157. doi: 10.1016/j.jclinepi.2012.01.006. PubMed DOI
Guyatt G.H., Oxman A.D., Kunz R., Atkins D., Brozek J., Vist G., Alderson P., Glasziou P., Falck-Ytter Y., Schunemann H.J. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J. Clin. Epidemiol. 2011;64:395–400. doi: 10.1016/j.jclinepi.2010.09.012. PubMed DOI
Guyatt G.H., Oxman A.D., Kunz R., Brozek J., Alonso-Coello P., Rind D., Devereaux P.J., Montori V.M., Freyschuss B., Vist G., et al. GRADE guidelines 6. Rating the quality of evidence—Imprecision. J. Clin. Epidemiol. 2011;64:1283–1293. doi: 10.1016/j.jclinepi.2011.01.012. PubMed DOI
Guyatt G.H., Oxman A.D., Kunz R., Woodcock J., Brozek J., Helfand M., Alonso-Coello P., Falck-Ytter Y., Jaeschke R., Vist G., et al. GRADE guidelines: 8. Rating the quality of evidence—Indirectness. J. Clin. Epidemiol. 2011;64:1303–1310. doi: 10.1016/j.jclinepi.2011.04.014. PubMed DOI
Guyatt G.H., Oxman A.D., Kunz R., Woodcock J., Brozek J., Helfand M., Alonso-Coello P., Glasziou P., Jaeschke R., Akl E.A., et al. GRADE guidelines: 7. Rating the quality of evidence—Inconsistency. J. Clin. Epidemiol. 2011;64:1294–1302. doi: 10.1016/j.jclinepi.2011.03.017. PubMed DOI
Guyatt G.H., Oxman A.D., Montori V., Vist G., Kunz R., Brozek J., Alonso-Coello P., Djulbegovic B., Atkins D., Falck-Ytter Y., et al. GRADE guidelines: 5. Rating the quality of evidence—Publication bias. J. Clin. Epidemiol. 2011;64:1277–1282. doi: 10.1016/j.jclinepi.2011.01.011. PubMed DOI
Guyatt G.H., Oxman A.D., Santesso N., Helfand M., Vist G., Kunz R., Brozek J., Norris S., Meerpohl J., Djulbegovic B., et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J. Clin. Epidemiol. 2013;66:158–172. doi: 10.1016/j.jclinepi.2012.01.012. PubMed DOI
Guyatt G.H., Oxman A.D., Sultan S., Glasziou P., Akl E.A., Alonso-Coello P., Atkins D., Kunz R., Brozek J., Montori V., et al. GRADE guidelines: 9. Rating up the quality of evidence. J. Clin. Epidemiol. 2011;64:1311–1316. doi: 10.1016/j.jclinepi.2011.06.004. PubMed DOI
Guyatt G.H., Oxman A.D., Vist G., Kunz R., Brozek J., Alonso-Coello P., Montori V., Akl E.A., Djulbegovic B., Falck-Ytter Y., et al. GRADE guidelines: 4. Rating the quality of evidence—Study limitations (risk of bias) J. Clin. Epidemiol. 2011;64:407–415. doi: 10.1016/j.jclinepi.2010.07.017. PubMed DOI
Guyatt G.H., Thorlund K., Oxman A.D., Walter S.D., Patrick D., Furukawa T.A., Johnston B.C., Karanicolas P., Akl E.A., Vist G., et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J. Clin. Epidemiol. 2013;66:173–183. doi: 10.1016/j.jclinepi.2012.08.001. PubMed DOI
Langan D., Higgins J.P.T., Jackson D., Bowden J., Veroniki A.A., Kontopantelis E., Viechtbauer W., Simmonds M. A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res. Synth. Methods. 2019;10:83–98. doi: 10.1002/jrsm.1316. PubMed DOI
Riley R.D., Higgins J.P., Deeks J.J. Interpretation of random effects meta-analyses. BMJ. 2011;342:549. doi: 10.1136/bmj.d549. PubMed DOI
Booth G.L., Kapral M.K., Fung K., Tu J.V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: A population-based retrospective cohort study. Lancet. 2006;368:29–36. doi: 10.1016/S0140-6736(06)68967-8. PubMed DOI
Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., Hu Z.X., Lin J., Xiao J.Z., Cao H.B., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–544. doi: 10.2337/diacare.20.4.537. PubMed DOI
Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., Keinanen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001;344:1343–1350. doi: 10.1056/NEJM200105033441801. PubMed DOI
Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M. Diabetes Prevention Program Research, G. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403. doi: 10.1056/NEJMoa012512. PubMed DOI PMC
Mensink M., Blaak E.E., Corpeleijn E., Saris W.H., de Bruin T.W., Feskens E.J. Lifestyle intervention according to general recommendations improves glucose tolerance. Obes. Res. 2003;11:1588–1596. doi: 10.1038/oby.2003.211. PubMed DOI
Kosaka K., Noda M., Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males. Diabetes Res. Clin. Pract. 2005;67:152–162. doi: 10.1016/j.diabres.2004.06.010. PubMed DOI
Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., Vijay V. Indian Diabetes Prevention, P. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia. 2006;49:289–297. doi: 10.1007/s00125-005-0097-z. PubMed DOI
Bo S., Ciccone G., Baldi C., Benini L., Dusio F., Forastiere G., Lucia C., Nuti C., Durazzo M., Cassader M., et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J. Gen. Intern. Med. 2007;22:1695–1703. doi: 10.1007/s11606-007-0399-6. PubMed DOI PMC
Bo S., Gambino R., Ciccone G., Rosato R., Milanesio N., Villois P., Pagano G., Cassader M., Gentile L., Durazzo M., et al. Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention. Am. J. Clin. Nutr. 2009;90:1502–1508. doi: 10.3945/ajcn.2009.28379. PubMed DOI
Penn L., White M., Oldroyd J., Walker M., Alberti K.G., Mathers J.C. Prevention of type 2 diabetes in adults with impaired glucose tolerance: The European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health. 2009;9:342. doi: 10.1186/1471-2458-9-342. PubMed DOI PMC
Eriksson K.F., Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia. 1991;34:891–898. doi: 10.1007/BF00400196. PubMed DOI
Penn L., White M., Lindstrom J., den Boer A.T., Blaak E., Eriksson J.G., Feskens E., Ilanne-Parikka P., Keinanen-Kiukaanniemi S.M., Walker M., et al. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE. 2013;8:e57143. doi: 10.1371/journal.pone.0057143. PubMed DOI PMC
Salas-Salvado J., Bullo M., Babio N., Martinez-Gonzalez M.A., Ibarrola-Jurado N., Basora J., Estruch R., Covas M.I., Corella D., Aros F., et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: Results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2011;34:14–19. doi: 10.2337/dc10-1288. PubMed DOI PMC
Salas-Salvado J., Bullo M., Estruch R., Ros E., Covas M.I., Ibarrola-Jurado N., Corella D., Aros F., Gomez-Gracia E., Ruiz-Gutierrez V., et al. Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial. Ann. Intern. Med. 2014;160:1–10. doi: 10.7326/M13-1725. PubMed DOI
Rücker G., Schwarzer G., Carpenter J.R., Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med. Res. Methodol. 2008;8:79. doi: 10.1186/1471-2288-8-79. PubMed DOI PMC
Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., Li H., Li H., Jiang Y., An Y., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet. 2008;371:1783–1789. doi: 10.1016/S0140-6736(08)60766-7. PubMed DOI
Lindstrom J., Peltonen M., Eriksson J.G., Ilanne-Parikka P., Aunola S., Keinanen-Kiukaanniemi S., Uusitupa M., Tuomilehto J. Improved lifestyle and decreased diabetes risk over 13 years: Long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS) Diabetologia. 2013;56:284–293. doi: 10.1007/s00125-012-2752-5. PubMed DOI
Lindstrom J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemio K., Hamalainen H., Harkonen P., Keinanen-Kiukaanniemi S., Laakso M., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–1679. doi: 10.1016/S0140-6736(06)69701-8. PubMed DOI
Diabetes Prevention Program Research Group 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686. doi: 10.1016/S0140-6736(09)61457-4. PubMed DOI PMC
Nathan D.M. Long-term complications of diabetes mellitus. N. Engl. J. Med. 1993;328:1676–1685. doi: 10.1056/NEJM199306103282306. PubMed DOI
de Mello V.D., Lindström J., Eriksson J., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Sundvall J., Laakso M., Tuomilehto J., Uusitupa M. Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: The Finnish Diabetes Prevention Study. Diabetes Care. 2012;35:211–217. doi: 10.2337/dc11-1272. PubMed DOI PMC
Salas-Salvado J., Diaz-Lopez A., Ruiz-Canela M., Basora J., Fito M., Corella D., Serra-Majem L., Warnberg J., Romaguera D., Estruch R., et al. Effect of a Lifestyle Intervention Program with Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial. Diabetes Care. 2019;42:777–788. doi: 10.2337/dc18-0836. PubMed DOI
Uusitupa M., Lindstrom J., Tuomilehto J. Prevention of type 2 diabetes-success story that is waiting for next steps. Eur. J. Clin. Nutr. 2018;72:1260–1266. doi: 10.1038/s41430-018-0223-x. PubMed DOI
Gong Q., Gregg E.W., Wang J., An Y., Zhang P., Yang W., Li H., Li H., Jiang Y., Shuai Y., et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: The China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011;54:300–307. doi: 10.1007/s00125-010-1948-9. PubMed DOI
Diabetes Prevention Program Research Group Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: The Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3:866–875. doi: 10.1016/S2213-8587(15)00291-0. PubMed DOI PMC
Uusitupa M., Peltonen M., Lindstrom J., Aunola S., Ilanne-Parikka P., Keinanen-Kiukaanniemi S., Valle T.T., Eriksson J.G., Tuomilehto J. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study—Secondary analysis of the randomized trial. PLoS ONE. 2009;4:e5656. doi: 10.1371/journal.pone.0005656. PubMed DOI PMC
Aro A., Kauppinen A., Kivinen N., Selander T., Kinnunen K., Tuomilehto J., Keinanen-Kiukaanniemi S., Lindstrom J., Uusitupa M., Kaarniranta K. Life Style Intervention Improves Retinopathy Status-The Finnish Diabetes Prevention Study. Nutrients. 2019;11:1691. doi: 10.3390/nu11071691. PubMed DOI PMC
Estruch R., Ros E., Salas-Salvado J., Covas M.I., Corella D., Aros F., Gomez-Gracia E., Ruiz-Gutierrez V., Fiol M., Lapetra J., et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N. Engl. J. Med. 2018;378:e34. doi: 10.1056/NEJMoa1800389. PubMed DOI
Diaz-Lopez A., Babio N., Martinez-Gonzalez M.A., Corella D., Amor A.J., Fito M., Estruch R., Aros F., Gomez-Gracia E., Fiol M., et al. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial. Diabetes Care. 2015;38:2134–2141. doi: 10.2337/dc15-1117. PubMed DOI
Look Ahead Research Group. Gregg E.W., Jakicic J.M., Blackburn G., Bloomquist P., Bray G.A., Clark J.M., Coday M., Curtis J.M., Egan C., et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: A post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4:913–921. doi: 10.1016/S2213-8587(16)30162-0. PubMed DOI PMC
Becerra-Tomas N., Blanco Mejia S., Viguiliouk E., Khan T., Kendall C.W.C., Kahleova H., Rahelic D., Sievenpiper J.L., Salas-Salvado J. Mediterranean diet, cardiovascular disease and mortality in diabetes: A systematic review and meta-analysis of prospective cohort studies and randomized clinical trials. Crit. Rev. Food Sci. Nutr. 2019 doi: 10.1080/10408398.2019.1565281. PubMed DOI
Nathan D.M., Bennett P.H., Crandall J.P., Edelstein S.L., Goldberg R.B., Kahn S.E., Knowler W.C., Mather K.J., Mudaliar S., Orchard T.J., et al. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia. 2019;62:1319–1328. doi: 10.1007/s00125-019-4928-8. PubMed DOI PMC
Aschner P. New IDF clinical practice recommendations for managing type 2 diabetes in primary care. Diabetes Res. Clin. Pract. 2017;132:169–170. doi: 10.1016/j.diabres.2017.09.002. PubMed DOI
Uusitupa M., Lindi V., Louheranta A., Salopuro T., Lindstrom J., Tuomilehto J. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes. 2003;52:2532–2538. doi: 10.2337/diabetes.52.10.2532. PubMed DOI
Kitabchi A.E., Temprosa M., Knowler W.C., Kahn S.E., Fowler S.E., Haffner S.M., Andres R., Saudek C., Edelstein S.L., Arakaki R., et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes. 2005;54:2404–2414. doi: 10.2337/diabetes.54.8.2404. PubMed DOI PMC
Hamman R.F., Horton E., Barrett-Connor E., Bray G.A., Christophi C.A., Crandall J., Florez J.C., Fowler S., Goldberg R., Kahn S.E., et al. Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS) Diabetes. 2015;64:989–998. doi: 10.2337/db14-0333. PubMed DOI PMC
Lean M.E., Leslie W.S., Barnes A.C., Brosnahan N., Thom G., McCombie L., Peters C., Zhyzhneuskaya S., Al-Mrabeh A., Hollingsworth K.G., et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial. Lancet. 2018;391:541–551. doi: 10.1016/S0140-6736(17)33102-1. PubMed DOI
Ley S.H., Hamdy O., Mohan V., Hu F.B. Prevention and management of type 2 diabetes: Dietary components and nutritional strategies. Lancet. 2014;383:1999–2007. doi: 10.1016/S0140-6736(14)60613-9. PubMed DOI PMC
Muraki I., Imamura F., Manson J.E., Hu F.B., Willett W.C., van Dam R.M., Sun Q. Fruit consumption and risk of type 2 diabetes: Results from three prospective longitudinal cohort studies. BMJ. 2013;347:f5001. doi: 10.1136/bmj.f5001. PubMed DOI PMC
Salas-Salvado J., Guasch-Ferre M., Diaz-Lopez A., Babio N. Yogurt and Diabetes: Overview of Recent Observational Studies. J. Nutr. 2017;147:1452–1461. doi: 10.3945/jn.117.248229. PubMed DOI
Meyer K.A., Kushi L.H., Jacobs D.R., Slavin J., Sellers T.A., Folsom A.R. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am. J. Clin. Nutr. 2000;71:921–930. doi: 10.1093/ajcn/71.4.921. PubMed DOI
Hodge A.M., English D.R., O’Dea K., Giles G.G. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care. 2004;27:2701–2706. doi: 10.2337/diacare.27.11.2701. PubMed DOI
Bazzano L.A., Li T.Y., Joshipura K.J., Hu F.B. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes care. 2008;31:1311–1317. doi: 10.2337/dc08-0080. PubMed DOI PMC
Villegas R., Gao Y.T., Yang G., Li H.L., Elasy T.A., Zheng W., Shu X.O. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women’s Health Study. Am. J. Clin. Nutr. 2008;87:162–167. doi: 10.1093/ajcn/87.1.162. PubMed DOI PMC
Ericson U., Sonestedt E., Gullberg B., Hellstrand S., Hindy G., Wirfalt E., Orho-Melander M. High intakes of protein and processed meat associate with increased incidence of type 2 diabetes. Br. J. Nutr. 2013;109:1143–1153. doi: 10.1017/S0007114512003017. PubMed DOI
von Ruesten A., Feller S., Bergmann M.M., Boeing H. Diet and risk of chronic diseases: Results from the first 8 years of follow-up in the EPIC-Potsdam study. Eur. J. Clin. Nutr. 2013;67:412–419. doi: 10.1038/ejcn.2013.7. PubMed DOI
Becerra-Tomas N., Diaz-Lopez A., Rosique-Esteban N., Ros E., Buil-Cosiales P., Corella D., Estruch R., Fito M., Serra-Majem L., Aros F., et al. Legume consumption is inversely associated with type 2 diabetes incidence in adults: A prospective assessment from the PREDIMED study. Clin. Nutr. 2018;37:906–913. doi: 10.1016/j.clnu.2017.03.015. PubMed DOI
Karamanos B., Thanopoulou A., Anastasiou E., Assaad-Khalil S., Albache N., Bachaoui M., Slama C.B., El Ghomari H., Jotic A., Lalic N., et al. Relation of the Mediterranean diet with the incidence of gestational diabetes. Eur. J. Clin. Nutr. 2014;68:8–13. doi: 10.1038/ejcn.2013.177. PubMed DOI
Reynolds A., Mann J., Cummings J., Winter N., Mete E., Te Morenga L. Carbohydrate quality and human health: A series of systematic reviews and meta-analyses. Lancet. 2019;393:434–445. doi: 10.1016/S0140-6736(18)31809-9. PubMed DOI
Fung T.T., Schulze M., Manson J.E., Willett W.C., Hu F.B. Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch. Intern. Med. 2004;164:2235–2240. doi: 10.1001/archinte.164.20.2235. PubMed DOI
Salas-Salvado J., Guasch-Ferre M., Lee C.H., Estruch R., Clish C.B., Ros E. Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome. J. Nutr. 2016;146:920–927. doi: 10.3945/jn.115.218487. PubMed DOI PMC
Jannasch F., Kroger J., Schulze M.B. Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies. J. Nutr. 2017;147:1174–1182. doi: 10.3945/jn.116.242552. PubMed DOI
Tonstad S., Stewart K., Oda K., Batech M., Herring R.P., Fraser G.E. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr. Metab. Cardiovasc. Dis. 2013;23:292–299. doi: 10.1016/j.numecd.2011.07.004. PubMed DOI PMC
Snowdon D.A., Phillips R.L. Does a vegetarian diet reduce the occurrence of diabetes? Am. J. Public Health. 1985;75:507–512. doi: 10.2105/AJPH.75.5.507. PubMed DOI PMC
Chiu T.H.T., Pan W.H., Lin M.N., Lin C.L. Vegetarian diet, change in dietary patterns, and diabetes risk: A prospective study. Nutr. Diabetes. 2018;8:12. doi: 10.1038/s41387-018-0022-4. PubMed DOI PMC
Zhang C., Tobias D.K., Chavarro J.E., Bao W., Wang D., Ley S.H., Hu F.B. Adherence to healthy lifestyle and risk of gestational diabetes mellitus: Prospective cohort study. BMJ. 2014;349:g5450. doi: 10.1136/bmj.g5450. PubMed DOI PMC
Mekary R.A., Giovannucci E., Willett W.C., van Dam R.M., Hu F.B. Eating patterns and type 2 diabetes risk in men: Breakfast omission, eating frequency, and snacking. Am. J. Clin. Nutr. 2012;95:1182–1189. doi: 10.3945/ajcn.111.028209. PubMed DOI PMC
Mekary R.A., Giovannucci E., Cahill L., Willett W.C., van Dam R.M., Hu F.B. Eating patterns and type 2 diabetes risk in older women: Breakfast consumption and eating frequency. Am. J. Clin. Nutr. 2013;98:436–443. doi: 10.3945/ajcn.112.057521. PubMed DOI PMC
Ballon A., Neuenschwander M., Schlesinger S. Breakfast Skipping Is Associated with Increased Risk of Type 2 Diabetes among Adults: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. J. Nutr. 2019;149:106–113. doi: 10.1093/jn/nxy194. PubMed DOI
Lindstrom J., Peltonen M., Eriksson J.G., Louheranta A., Fogelholm M., Uusitupa M., Tuomilehto J. High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: The Finnish Diabetes Prevention Study. Diabetologia. 2006;49:912–920. doi: 10.1007/s00125-006-0198-3. PubMed DOI
Sylvetsky A.C., Edelstein S.L., Walford G., Boyko E.J., Horton E.S., Ibebuogu U.N., Knowler W.C., Montez M.G., Temprosa M., Hoskin M., et al. A High-Carbohydrate, High-Fiber, Low-Fat Diet Results in Weight Loss among Adults at High Risk of Type 2 Diabetes. J. Nutr. 2017;147:2060–2066. doi: 10.3945/jn.117.252395. PubMed DOI PMC
Wu J.H.Y., Marklund M., Imamura F., Tintle N., Ardisson Korat A.V., de Goede J., Zhou X., Yang W.S., de Oliveira Otto M.C., Kröger J., et al. Omega-6 fatty acid biomarkers and incident type 2 diabetes: Pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017;5:965–974. doi: 10.1016/S2213-8587(17)30307-8. PubMed DOI PMC
Schwab U., Lauritzen L., Tholstrup T., Haldorssoni T., Riserus U., Uusitupa M., Becker W. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: A systematic review. Food Nutr. Res. 2014;58:25145. doi: 10.3402/fnr.v58.25145. PubMed DOI PMC
Laaksonen D.E., Lindstrom J., Lakka T.A., Eriksson J.G., Niskanen L., Wikstrom K., Aunola S., Keinanen-Kiukaanniemi S., Laakso M., Valle T.T., et al. Physical activity in the prevention of type 2 diabetes: The Finnish diabetes prevention study. Diabetes. 2005;54:158–165. doi: 10.2337/diabetes.54.1.158. PubMed DOI
Aune D., Norat T., Leitzmann M., Tonstad S., Vatten L.J. Physical activity and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis. Eur. J. Epidemiol. 2015;30:529–542. doi: 10.1007/s10654-015-0056-z. PubMed DOI
Burr J.F., Rowan C.P., Jamnik V.K., Riddell M.C. The role of physical activity in type 2 diabetes prevention: Physiological and practical perspectives. Phys. Sportsmed. 2010;38:72–82. doi: 10.3810/psm.2010.04.1764. PubMed DOI
Lifestyle Medicine in Diabetes Care: The Lifedoc Health Model